Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
Active, not recruiting · NCT05710315 · Registry updated 2026-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure | Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, exocrine pancreatic insufficiency, multiple organ dysfunction syndrome, pancreas disorder | Active, not recruiting | Not applicable | 2026-07-01 | NCT05710315 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alcresta Therapeutics, Inc. | 5 |
| Inova Health Care Services | 27 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Inova Fairfax Medical Campus | Falls Church | United States | 29 |